Czechia· CZ-0222874
STEGLUJAN
A sitagliptin and ertugliflozin product containing ertugliflozin pidolic acid + sitagliptin phosphate monohydrate, registered in Czechia by Merck Sharp & Dohme B.V., Haarlem. The same ATC class is registered in 10 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Sitagliptin and ertugliflozin is registered in 10 of 19 countries.
Countries holding a registration under ATC A10BD24 (sitagliptin and ertugliflozin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Sitagliptin and ertugliflozin · ATC A10BD24
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ERTUGLIFLOZIN PIDOLIC ACID + SITAGLIPTIN PHOSPHATE MONOHYDRATE
- Manufacturer
- Merck Sharp & Dohme B.V., Haarlem
- Country
- Czechia (CZ)
- ATC code
- A10BD24
- ATC class
- Sitagliptin and ertugliflozin
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sitagliptin and ertugliflozin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandSteglujanMerck Sharp & Dohme B.V.
- SwitzerlandSteglujan 5 mg /100 mg, FilmtablettenMSD Merck Sharp & Dohme AG
- IcelandSteglujanMerck Sharp & Dohme B.V.*
- SwedenSteglujan 15 mg/100 mg Filmdragerad tablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Steglujan
- Liechtenstein · Steglujan
- Norway · Steglujan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7b8c347-9d2b-43a7-8a78-cc898e396e30 GET /v1/drugs/e7b8c347-9d2b-43a7-8a78-cc898e396e30?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "15MG/100MG",
"pack_size": "30X1",
"substance": "ERTUGLIFLOZIN PIDOLIC ACID + SITAGLIPTIN PHOSPHATE MONOHYDRATE",
"cz_kod_sukl": "0222874",
"product_type": "CH",
"substance_codes": "21651,17916",
"registration_state": "R",
"registration_number": "EU/1/18/1266/010"
}See everything about sitagliptin and ertugliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.